http://www.cxoadvisory.com/blog/internal/blog6-26-09/In summary, very limited evidence suggests that biotech stocks tend to be weak in late winter, strong in late summer and December, and weak during most of the fall. The late summer strength is most distinctive.Hey Tom, great link! Thank you for posting it.August and September there look pretty serious on the upside. Combined with all the excitement over premiums liked MEDX just got? Potent combo.. little bio's are popping up the charts all over the place. Even ARRY my little (previous loser) contest pick was up 30-40% in the last two days.Sarah
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar